Skip to main content

Table 3 VAS

From: Effect of caffeine on delayed-onset muscle soreness: a meta-analysis of RCT

Author

Caffeine

Placebo

N

Mean

SD

N

Mean

SD

A) VAS Pre-exercise

Lorruama J

9

4.7

3.67

9

4.9

3.37

Caitlin F

9

0.149

0.179

9

0.298

0.417

Maridakis V

9

2.66

1.56

9

1.82

1.08

UMD (95% CI)

 − 0.00 (− 0.51, 0.50)

     

B) VAS Post-exercise

Al-Nawaiseh AM

11

3.927

2.235

11

4.009

1.956

Maridakis V

9

1.39

1.31

9

1.63

0.89

UMD (95% CI)

 − 0.20 (− 1.09, 0.69)

     

C) VAS at 24 h

Chen HY

10

0.7525

0.1303

10

0.865

0.069

Lorruama J

9

5

3.38

9

5.5

3.08

Caitlin F

9

2.59

1.25

9

3.571

0.506

Al-Nawaiseh AM

11

5.506

1.64

11

5.022

1.38

Maridakis V

9

0.95

1.03

9

2.2

1.03

Nobahar M

8

2.5

0.175

8

5

0.175

Caldwell AR

12

1.45

2.45

18

2.78

1.67

UMD (95% CI)

 − 0.92 (− 2.20, 0.36)

     

D) VAS at 48 h

Caitlin F

9

2.5

1.25

9

4.107

0.506

Al-Nawaiseh AM

11

5.3

2.204

11

3.973

2.207

Maridakis V

9

0.56

1.02

9

1.81

1.01

Caldwell AR

12

0.45

0.78

18

1.78

1.33

UMD (95% CI)

 − 1.02 (− 1.86, − 0.19)

     

E) VAS at 72 h

Caitlin F

9

1.369

0.476

9

1.786

0.923

Caldwell AR

12

1

0.88

18

1.22

1.1

UMD (95% CI)

0.0 (− 0.36, 0.36)

     

F) VAS at 96 h

Caitlin F

9

0.952

0.774

9

0.774

0.833

UMD (95% CI)

0.18 (− 0.56, 0.96)

    Â